Pieris achieves milestone payment in Sanofi collaboration
Pieris AG has achieved a preclinical milestone within its R&D collaboration with Sanofi, triggering an undisclosed payment, the company announced. The milestone relates to the generation of sub-nanomolar Anticalins® against multiple targets within a single therapeutic program, forming the building blocks for a multispecific program.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.